Study of PF-04523655 (REDD14NP) In Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (Wet AMD)
Clinical trial NCT00725686 · COMPLETED
Trial details
- NCT number
- NCT00725686
- Sponsor
- Quark Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2010-11-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.